These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: New vaccine+HAART treatment trial enrolling at NIH. National Institutes of Health.
    Author: James JS.
    Journal: AIDS Treat News; 1998 Aug 07; (No 300):3-4. PubMed ID: 11365687.
    Abstract:
    The National Institutes of Health (NIH) is beginning a trial that includes a new HIV vaccine plus standard antiretroviral therapy, and which may restore HIV immune function in some patients. Volunteers must have a CD4 count of over 500 and either be on treatment or willing to begin treatment. All study medications will be provided during the 18-month trial, and NIH will pay the majority of transportation costs. Contact information is provided for people interested in participating.
    [Abstract] [Full Text] [Related] [New Search]